Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer

In recent years, combining different types of therapy has emerged as an advanced strategy for cancer treatment. In these combination therapies, oral delivery of anticancer drugs is more convenient and compliant. This study developed an irinotecan/rapamycin-loaded oral lecithin-based self-nanoemulsif...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Hsuan, Chen, Ling-Chun, Cheng, Wen-Ting, Wei, Pu-Sheng, Hsieh, Chien-Ming, Sheu, Ming-Thau, Lin, Shyr-Yi, Ho, Hsiu-O, Lin, Hong-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963937/
https://www.ncbi.nlm.nih.gov/pubmed/36839795
http://dx.doi.org/10.3390/pharmaceutics15020473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963937/
https://www.ncbi.nlm.nih.gov/pubmed/36839795
http://dx.doi.org/10.3390/pharmaceutics15020473

Ejemplares similares